PRI's Focus on Health Care
View this email in your browser ([link removed])
[link removed]
Quality Adjust Life Years in Healthcare Disguise Bigotry
Newsmax | Sally Pipes
April 29, 2022
What’s the value of a human life? It’s a most provocative question.
In socialized healthcare systems globally, that question is at the center of every decision public officials make: how much money to spend on care, whether to approve an innovative new drug or medical device for use, who gets timely access to treatment, and who has to wait, and so forth.
Read more. . . ([link removed])
New Brief: Broken System Imposes Higher Out-Of-Pocket Costs on Patients, Puts Interests of Government and Insurers First
Coverage Denied | Dr. Wayne Winegarden
April 28, 2022
America’s broken third-party healthcare payment system prioritizes government and insurance companies as the largest payers, leaving patients with higher out-of-pocket costs, greater exposure to healthcare financial risk, and reduced access to care – finds the latest paper in the Coverage Denied ([link removed]) series released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute.
Read more. . . ([link removed])
Biden must not kill off short-term health plans
Washington Examiner | Sally Pipes
May 2, 2022
Democratic lawmakers are looking to limit patient choice in the health insurance market.
Forty of them just sent a letter ([link removed]) to the Biden administration urging regulators to undo a Trump-era rule that expanded access to short-term health plans. President Joe Biden is sympathetic to their pleas. He called short-term plans “junk” during his 2020 campaign. But his administration has yet to roll back Donald Trump’s rule.
Read more. . . ([link removed])
The U.S. Should Not Be Funding The WHO Follies
Issues & Insights | Henry Miller
May 4, 2022
The two-years-plus of the COVID-19 pandemic should be a wakeup call that there is something very wrong – irreparable, even – at the chronically inept World Health Organization (WHO). Two recent transgressions show that the bureaucrats there are not getting any smarter.
The first is almost inconceivable. Medicago, a Canadian company, developed a COVID-19 vaccine ([link removed]) synthesized in the Nicotiniana plant, a relative of tobacco. In clinical testing, it showed ([link removed]) efficacy against all variants studied prior to the emergence of Omicron of 71% ([link removed]) , and for the Delta variant specifically of 75%.
Read more . . . ([link removed])
============================================================
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
Copyright © 2022 *Pacific Research Institute*, All rights reserved.
You are receiving this email because you opted in via our website.
Our mailing address is:
P.O. Box 60485 | Pasadena, CA 91116
Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.
